Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human monoclonal IgM antibody targeting glucose-regulated protein 78

EU orphan designation number: EU/3/13/1190   
Active ingredient: Recombinant human monoclonal IgM antibody targeting glucose-regulated protein 78
Indication: Treatment of plasma cell myeloma
Sponsor: Patrys GmbH
c/o RSM Verhülsdonk GmbH, Georg- Glock-Straße 4, 40474 Düsseldorf, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
09/10/2013 Orphan designation EMA/OD/072/13 (2013)6735 of 07/10/2013
11/11/2016 Change of name and/or address of sponsor EMA/OD/072/13